MedPath

Sequential therapy for hepatocellular carcinoma -Real world evidence of TKI in prospective observational study

Not Applicable
Recruiting
Conditions
hepatocellular carcinoma
Registration Number
JPRN-UMIN000038867
Lead Sponsor
Kyushu Study group of Clinical Cancer
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
500
Inclusion Criteria

Not provided

Exclusion Criteria

#1.Patients with a past history of treatment for systemic therapy #2.Patients participating in another interventional clinical trials

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Overall survival from 1st line treatment (including subsequent therapies)
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath